NeoStem and Mass. Eye and Ear/Schepens Eye Research Institute Announce Second Research Collaboration Exploring NeoStem’s VSEL™ Technology for Retinal Repair
Dr. Robin Smith was featured live for a second time on Clear Channel's "the Traders Network" DFW 1190AM radio broadcast hosted by Michael Yorba. Read the press release and listen to the broadcast archive.
Dr. Robin Smith was featured live on Clear Channel's "the Traders Network" DFW 1190AM radio broadcast hosted by Michael Yorba. Read the press release and listen to the broadcast archive.
Dr. Robin Smith was interviewed in the November issue of Life Science Leader magazine in which she discussed the Company's future development and its innovative relationship with the Vatican.
NeoStem - Transforming the Treatment of Chronic Disease
NeoStem, Inc. is a leader in the emerging cellular therapy industry. Our business model includes the development of novel proprietary cell therapy products as well as operating a contract development and manufacturing organization providing services to others in the regenerative medicine industry. The combination of a therapeutic development business and revenue-generating service provider business provides the Company with capabilities for cost effective in-house product development and immediate revenue and cash flow generation.